Elutia receives $8 million payment from Boston Scientific, is fully funded into 2029
ELUT•Elutia received an $8 million payment from Boston Scientific and said it is fully funded into 2029; it continues to expect a favorable FDA clearance decision for NXT-41X in the first half of 2027.
1. Payment and outlook
Elutia received an $8 million payment from Boston Scientific, and the company said it is now fully funded into 2029. Elutia continues to expect a favorable FDA clearance decision for NXT-41X in the first half of 2027.
